Langerhans Cell Histiocytosis
Also known as: LCH, childhood Langerhans cell histiocytosis, diffuse reticuloendotheliosis, eosinophilic granuloma , histiocytosis x and others.
What is Langerhans cell histiocytosis?
Langerhans cell histiocytosis (LCH) is a rare disease of children (most commonly between the ages of 1-3 years; boys more often than girls) in which a certain immature normal white blood type (Langerhans cells, a type of histiocyte) grows uncontrollably and rapidly in almost any organ (there appears to be debate as to whether this is a form of cancer or not).
What causes Langerhans cell histiocytosis?
The cause is unknown, however gene mutations have been found in about half the patients.
What are the symptoms of Langerhans cell histiocytosis?
Symptoms depend on which tissue(s) or organ(s) the cell multiplies in. They include fever, weakness and tiredness, bone involvement (78%) which often presents as swelling or a lump, or fractures of bone that occur for no reason (or small injury), skin rashes ( 50% of patients ), lung damage (~ 20-40%), swollen lymph nodes (~30%), ear infections, liver problems and many others.
What are Langerhans cell histiocytosis care options?
Children with localized disease may require no treatment. In some cases, surgery to remove the tumor, low-dose radiation therapy and chemotherapy may be utilized.
Reviewed by: Jack Wolfsdorf, MD, FAAP
This page was last updated on: 5/23/2018 2:38:15 PM
Camp U.O.T.S. is an annual weeklong, overnight camp for children with cancer and blood disorders who are treated at Nicklaus Children’s Hospital.
Learn more and register
From the Newsdesk
More than two dozen children attended the Bear Hug camp at Nicklaus Children's last week. This day camp is for siblings of pediatric cancer patients to encourage socialization among peers and help them gain insight on their siblings' care journey.
On this very same day nine years ago, Daniella Alvarez was diagnosed Teratoid Rhabdoid Tumor (ATRT), a rare and aggressive type of brain cancer. The news came on June 26, 2009, her second birthday. Daniella endured years of brain surgeries, aggressive chemotherapies, radiation, imaging scans, multiple visits to intensive care at Nicklaus Children’s Hospital. She is now cancer free thanks to a pediatric clinical trial made possible through research funding.
Dr. Toba N. Niazi, Neurosurgeon, and Dr. Ziad A. Khatib, Hematologist and Oncologist, discuss the second leading cause of cancer in children, brain tumors.